Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

1.

Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.

Raz I, Stranks S, Filipczak R, Joshi P, Lertoft B, Rastam J, Chow CC, Shaban J.

Clin Ther. 2005 Sep;27(9):1432-43.

PMID:
16291416
[PubMed - indexed for MEDLINE]
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
3.

Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

Clin Ther. 2005;27 Suppl B:S57-74. Review.

PMID:
16519038
[PubMed - indexed for MEDLINE]
4.

Biphasic insulin aspart 30: literature review of adverse events associated with treatment.

Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R.

Clin Ther. 2005;27 Suppl B:S75-88. Review.

PMID:
16519039
[PubMed - indexed for MEDLINE]
5.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
[PubMed - indexed for MEDLINE]
6.

Biphasic insulin aspart in type 2 diabetes mellitus: an evidence-based medicine review.

Gough SC, Tibaldi J.

Clin Drug Investig. 2007;27(5):299-324. Review.

PMID:
17451279
[PubMed - indexed for MEDLINE]
8.

Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.

Rosenstock J, Fitchet M.

Int J Clin Pract Suppl. 2008 Mar;(159):15-23. doi: 10.1111/j.1742-1241.2007.01692.x. Review.

PMID:
18269437
[PubMed - indexed for MEDLINE]
9.

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus.

Chilcott J, Tappenden P, Jones ML, Wight JP.

Clin Ther. 2001 Nov;23(11):1792-823; discussion 1791. Review.

PMID:
11768834
[PubMed - indexed for MEDLINE]
10.

Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus.

Culy CR, Jarvis B.

Drugs. 2001;61(11):1625-60. Review.

PMID:
11577798
[PubMed - indexed for MEDLINE]
11.

Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.

Setter SM, Iltz JL, Thams J, Campbell RK.

Clin Ther. 2003 Dec;25(12):2991-3026. Review.

PMID:
14749143
[PubMed - indexed for MEDLINE]
12.

Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.

Yki-Järvinen H.

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S77-81. Review.

PMID:
12324990
[PubMed - indexed for MEDLINE]
13.

Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone.

Bailey CJ, Green BD, Flatt PR.

Expert Opin Investig Drugs. 2010 Aug;19(8):1017-25. doi: 10.1517/13543784.2010.505235. Review.

PMID:
20629618
[PubMed - indexed for MEDLINE]
14.

Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes.

Yamanouchi T.

Vasc Health Risk Manag. 2010 Apr 15;6:189-97. Review.

PMID:
20407626
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Promising new approaches.

Reasner CA 2nd.

Diabetes Obes Metab. 1999 May;1 Suppl 1:S41-8. Review.

PMID:
11220287
[PubMed - indexed for MEDLINE]
16.

Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.

Clar C, Royle P, Waugh N.

PLoS One. 2009 Jul 1;4(7):e6112. doi: 10.1371/journal.pone.0006112. Review.

PMID:
19568428
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione.

Braunstein S.

Clin Ther. 2003 Jul;25(7):1895-917. Review.

PMID:
12946541
[PubMed - indexed for MEDLINE]
18.

Long-term glycaemic control with pioglitazone in patients with type 2 diabetes.

Campbell IW.

Int J Clin Pract. 2004 Feb;58(2):192-200. Review. Erratum in: Int J Clin Pract. 2004 Oct;58(10):993.

PMID:
15055868
[PubMed - indexed for MEDLINE]
19.

Biphasic insulin aspart in the treatment of type 2 diabetes mellitus.

Cucinotta D, Russo GT.

Expert Opin Pharmacother. 2009 Dec;10(17):2905-11. doi: 10.1517/14656560903391714. Review.

PMID:
19929709
[PubMed - indexed for MEDLINE]
20.

Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment.

Triplitt C, Cersosimo E, DeFronzo RA.

Vasc Health Risk Manag. 2010 Sep 7;6:671-90. Review.

PMID:
20859539
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk